CClinicalTrials.gg
Not yet recruitingNCT06442722Updated Jun 4, 2024

Surgical Treatment of DDH With and Without Capsulorrhaphy

An interventional study of DDH with capsulorrhaphy and DDH without capsulorrhaphy in Developmental Dysplasia of the Hip, sponsored by Sohag University. Not yet recruiting at 1 site in Egypt. Open to participants aged 1 Year to 6 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-06-04.

Sponsored by Sohag University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jun 2025, 1 year 4 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
1 Year to 6 Years
Sex
All
01

Study summary

The goal of this interventional study is to evaluates the surgical treatment outcomes of Developmental Dysplasia of Hip with and without capsulorrhaphy between 1-6 years of age . it compares the effectiveness of these approaches in improving postoperative stability , range of motion , and long-term success rates for DDH patients undergoing surgery .:

02

Conditions studied

  • Developmental Dysplasia of the Hip
03

In context

Developmental Dysplasia of the Hip

114 studies on the registry are indexed under Developmental Dysplasia of the Hip; 17 are open to participants now.

This study's planned enrollment of 50 is below the median of 61 across 71 interventional studies indexed under Developmental Dysplasia of the Hip.

Browse Developmental Dysplasia of the Hip studies →

Lead sponsor

Sohag University is the lead sponsor of 1,183 studies on the registry; 612 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Year to 6 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. age: from 1 year to 6 years
  2. sex: males and females
  3. Children who received no operative treatment before.

Exclusion criteria

Exclusion Criteria:

  1. Children who were treated operatively before presentation.
  2. Children who had teratologic, post septic or neuromuscular hip dislocation.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
50 participants (estimated)

Study arms

  • Active comparator
    DDH with capsulorrhaphy

    one group will undergo capsulorrhaphy, a surgical procedure to tighten the hip capsule

    Procedure: DDH with capsulorrhaphy

  • Active comparator
    DDH without capsulorrhaphy

    group has no tightness of the hip capsule

    Procedure: DDH without capsulorrhaphy

Interventions

  • ProcedureDDH with capsulorrhaphy

    group will undergo capsulorrhaphy, a surgical procedure to tighten the hip capsule ,

  • ProcedureDDH without capsulorrhaphy

    group will not undergo capsulorrhaphy, a surgical procedure without tightness the hip capsule

06

What researchers measure

Primary outcomes

  1. Severin's grading

    radiological

    Time frame: 1 year

07

Study locations

1 site
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 4, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06442722
Lead sponsor
Sohag University
Responsible party
Ali Abdelaal Bakheet (assistant lecturer, Sohag University) — Principal investigator
First posted
Jun 4, 2024
Start date
Jun 2, 2024 (estimated)
Primary completion
Jun 2, 2025 (estimated)
Completion
Dec 1, 2025 (estimated)
Last update
Jun 4, 2024

Study contacts

Ali Bakheet, ass. lecturer
Contact
ali.mohamed@med.sohag.edu.eg
020-01010505552

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion